Vivos Therapeutics CFO Bradford Amman's 2021 pay jumps 311% to $1.1M
Vivos Therapeutics reports 2021 executive compensation
By ExecPay News
Published: July 14, 2022
Vivos Therapeutics reported fiscal year 2021 executive compensation information on July 14, 2022.
In 2021, three executives at Vivos Therapeutics received on average a compensation package of $877K, a 157% increase compared to previous year.
Average pay of disclosed executives at Vivos Therapeutics
Bradford Amman, Chief Financial Officer, received $1.1M in total, which increased by 311% compared to 2020. 73% of Amman's compensation, or $806K, was in option awards. Amman also received $52K in non-equity incentive plan, $230K in salary, as well as $18K in other compensation.
R. Kirk Huntsman, Chief Executive Officer, received a compensation package of $1.1M, which increased by 137% compared to previous year. 53% of the compensation package, or $570K, was in option awards.
G. Dave Singh, Chief Medical Officer, earned $447K in 2021, a 50% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on July 14, 2022.